WACKER launches contract research services to accelerate next-gen RNA & DNA therapies
The new CRS offering is delivered from WACKER’s Biotechnology Center in Munich
The new CRS offering is delivered from WACKER’s Biotechnology Center in Munich
The value of the contract is estimated to be between Rs 20-30 crores per year for the next three years
Subscribe To Our Newsletter & Stay Updated